CRVS : Insider Transactions for Corvus Pharmaceuticals, Inc.

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Corvus Pharmaceuticals, Inc. (CRVS)

$2.03

0.07 (3.57%) as of 4:30 Thu 5/9

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

28,040,000

Market Cap:

56.92(M)

Last Volume:

Avg Vol:

52 Week Range:

$1.08 - $3.86

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : 12.1

Insider 6 Months : 12.1

Insider 3/6 Months : 24.4

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Corvus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of immune modulator product candidates to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. Co.'s lead product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73. Co.'s next product candidate, CPI-818, is a selective, covalent inhibitor of ITK and is in a multi-center Phase 1/1b clinical trial in patients with various malignant T-cell lymphomas. Co.'s third product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	597,634	597,634	607,634	782,524
Total Buy Value	$1,034,624	$1,034,624	$1,059,124	$1,196,645
Total People Bought	2	2	3	4
Total Buy Transactions	2	2	3	14
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-09	2023-11-08	2023-05-10	2022-05-10

Adjust Filter Settings

Records found: 112

Page 3 of 5

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Lea Leiv

Chief Financial Officer

• – –

2019-06-06

$3.56

$55,180

I/I

15,500

40,200

1.99

Miller Richard A Md

President and CEO

• • –

2018-12-27

$3.29

$65,884

I/I

20,000

1,128,795

2.66

Lea Leiv

Chief Financial Officer

• – –

2018-12-21

$4.15

$102,409

I/I

24,700

1.99

Miller Richard A Md

President and CEO

• • –

2018-12-20

$4.39

$43,950

I/I

10,000

1,108,795

2.66

Miller Richard A Md

President and CEO

• • –

2018-12-11

$0.00

I/I

20,000

1,098,795

Miller Richard A Md

President and CEO

• • –

2018-12-06

$5.99

$29,934

I/I

5,000

1,118,795

2.66

Miller Richard A Md

President and CEO

• • –

2018-12-04

$5.95

$8,937

I/I

1,502

1,113,795

2.58

Thompson Peter A

Director

– • •

2018-03-12

$8.50

$4,999,998

I/I

588,235

5,967,584

2.25

Orbimed Capital Gp V Llc

Director

– • •

2018-03-12

$8.50

$4,999,998

I/I

588,235

5,967,584

2.25

Novo A/s

10% Owner

– – •

2018-03-12

$8.50

$9,999,995

D/D

1,176,470

4,420,516

2.45

Gould Terry P

Director

– • •

2018-03-12

$8.50

$4,999,998

I/I

588,235

126,806

2.25

Adams Street Partners Llc

10% Owner

– – •

2018-03-12

$8.50

$4,999,998

I/I

588,235

126,806

1.5

Miller Richard A Md

President and CEO

• • –

2018-03-12

$8.50

$850,000

I/I

100,000

1,112,293

2.66

Miller Richard A Md

President and CEO

• • –

2017-11-20

$10.79

$107,850

I/I

10,000

1,012,293

2.66

Novo A/s

10% Owner

– – •

2017-06-23

$10.95

$219,000

D/D

20,000

3,244,046

2.45

Miller Richard A Md

President and CEO

• • –

2017-06-13

$9.75

$49,725

I/I

5,000

1,002,293

2.66

Miller Richard A Md

President and CEO

• • –

2017-06-12

$9.82

$110,185

I/I

11,216

997,293

2.66

Miller Richard A Md

President and CEO

• • –

2017-06-09

$9.89

$87,174

I/I

8,784

986,077

2.66

Miller Richard A Md

President and CEO

• • –

2016-10-28

$0.00

I/I

100,000

977,293

Thompson Peter A

Director

– • •

2016-06-24

$12.99

$11,691

I/I

900

5,379,349

2.17

Isaly Samuel D

Director

– • •

2016-06-24

$12.99

$11,691

I/I

900

5,379,349

2.17

Thompson Peter A

Director

– • •

2016-06-23

$12.92

$1,292

I/I

100

5,378,449

2.17

Isaly Samuel D

Director

– • •

2016-06-23

$12.92

$1,292

I/I

100

5,378,449

2.17

Thompson Peter A

Director

– • •

2016-06-21

$12.87

$335,688

I/I

26,083

5,378,349

2.25

Isaly Samuel D

Director

– • •

2016-06-21

$12.87

$335,688

I/I

26,083

5,378,349

2.25

112 Records found	1 2 3 4 5	Page 3 of 5

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: